about
Clinical Relevance of Biomarkers of Oxidative StressNovel methodologies for biomarker discovery in atherosclerosisExogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice.The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of AtherosclerosisMitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation.Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.The effect of RO3201195 and a pyrazolyl ketone P38 MAPK inhibitor library on the proliferation of Werner syndrome cells.Effects of Allopurinol on Arterial Stiffness: A Meta-Analysis of Randomized Controlled TrialsChronic vagal nerve stimulation prevents high-salt diet-induced endothelial dysfunction and aortic stiffening in stroke-prone spontaneously hypertensive rats.CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.Monocytic MKP-1 is a Sensor of the Metabolic Environment and Regulates Function and Phenotypic Fate of Monocyte-Derived Macrophages in Atherosclerosis.Chronic adventitial inflammation, vasa vasorum expansion, and 5-lipoxygenase up-regulation in irradiated arteries from cancer survivors.Role of Mitochondria-Associated Endoplasmic Reticulum Membrane in Inflammation-Mediated Metabolic DiseasesTargeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.Quercetin Inhibits LPS-Induced Inflammation and ox-LDL-Induced Lipid DepositionMacrophagic CD146 promotes foam cell formation and retention during atherosclerosisPreventive Role of Tetraspanin CD9 in Systemic Inflammation of Chronic Obstructive Pulmonary Disease.Role of neutrophils in atherogenesis: an update.Protective role of sulphoraphane against vascular complications in diabetes.The effects of endoplasmic reticulum stress inducer thapsigargin on the toxicity of ZnO or TiO2 nanoparticles to human endothelial cells.C1q/TNF-related protein 9 inhibits the cholesterol-induced Vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP-dependent kinase.Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis.Fisetin and Its Role in Chronic Diseases.Therapeutic Targeting of Cellular Stress to Prevent Cardiovascular Disease: A Review of the Evidence.Nucleic Acid Delivery for Endothelial Dysfunction in Cardiovascular DiseasesLocal Inhibition of Macrophage and Smooth Muscle Cell Proliferation to Suppress Plaque Progression.The immunology of atherosclerosis.Recent advances and clinical insights into the use of proteomics in the study of atherosclerosis.Bioactive lipids in aortic valve stenosis-a possible link to atherosclerosis?Serum bilirubin concentrations and incident coronary heart disease risk among patients with type 2 diabetes: the Dongfeng-Tongji cohort.Capturing LTA4 hydrolase in action: Insights to the chemistry and dynamics of chemotactic LTB4 synthesis.Hyaluronan synthase 3 promotes plaque inflammation and atheroprogression.Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis.Traditional Chinese Medicine Protects against Cytokine Production as the Potential Immunosuppressive Agents in Atherosclerosis.MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesisThermoneutral Housing Accelerates Metabolic Inflammation to Potentiate Atherosclerosis but Not Insulin Resistance.Stress: the good, the bad and the ugly?Omega-3 fatty acids in atherosclerosis and coronary artery disease.DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
P2860
Q26785512-76CE92E6-AA76-4471-8212-6646E23962B6Q28088373-996FA1B2-7FA7-47C2-BBAD-EEB2B9AAD7A5Q33789826-CF84977D-4062-4178-9A90-064DB2F5D70DQ33838927-C27E6CBE-DB65-4488-8E0A-4265F441CD0DQ34524163-5B5A37F8-9F5C-4820-B24D-6A2F497412A1Q35640438-E5AD2A09-C14F-4C8D-8F0A-99EA22878C97Q35854103-8FA386EE-0D55-469F-9059-F8AE2F188605Q35998065-2AADE5F9-313B-4BB0-BF6B-C9568EB97A01Q37139632-B9D53496-280B-44AF-BF07-3F794749702BQ37165792-29B1BD28-0097-4AB3-BEBB-DFD2B30EF5ADQ37285552-A137D52A-A4F1-4C11-9F58-87CB47E03449Q37344849-605C6C96-5348-4E61-9FAD-2A5A8593F88EQ37542677-8C063F25-CC90-4FED-AF78-C216491EE80AQ37544674-0754CFE2-1CA9-4803-88D6-4F3263ED869EQ37622040-8CBD01D1-53A4-498D-B1F4-BE5199169B4AQ37683992-3053582D-BA23-452E-9D4D-8354679FB7E1Q38588362-436E8986-D8F2-4751-A3AD-D1FC9B0E5111Q38634721-A9B5862A-9481-40CB-8256-73D4E0F807E1Q38721709-4DF88BBC-D9A2-4407-8D2C-C5CF0F640E1BQ38725270-C4675D8D-5BE1-4DCD-9001-3228243A74CBQ38775075-8D484D9B-1D3B-4987-BA7E-D5FA209024BDQ38786058-C5CFBD4C-B81E-4BD4-8865-0319BE1BE0B5Q38881790-C5B92151-09AB-4A48-BAB6-0B58A6E520AFQ38965216-7E04C027-7B24-4A7A-A98B-E1699172824DQ38990014-06501C61-83D5-4342-8E99-E28D3381837CQ39003359-11B1CD66-7205-4C15-99FD-850FB9D82FCCQ39003364-EB41CC5F-12B8-44C5-947B-4B76B3EDC7F7Q39230390-32E6CEA5-8CBE-49CB-BA83-B00F26BF2CF6Q39423557-F57F0362-DD75-47AA-A2DF-BA0AC1A9EC3AQ40062794-8BBF0FFC-AD81-450E-84CF-E680AD47B946Q40433462-D5772447-10CF-4D72-B81F-09D6EAAD5EA8Q41267047-BF216445-598E-4660-9D7D-38E3663BDA8BQ41990038-290871FD-68FE-4F45-84A3-838930CC94B1Q42052307-A5405F56-A6B0-4860-99FA-69C6944C7233Q42361233-7257AB5B-BB20-424A-A257-B032C97F9B25Q42362245-1950DFFE-0223-42E8-ACE4-3E0E286ADAE9Q43085184-A623CB09-C06F-4FF6-8991-8A0602198060Q44144719-D74F04BD-12B8-4250-A21C-00100F99D1D5Q46222465-6F89C306-C982-4B0C-9EA4-EBDB751A3F4AQ47103922-C15E19BF-42B8-4300-BFED-86C1292590B2
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Anti-inflammatory therapies for atherosclerosis.
@en
type
label
Anti-inflammatory therapies for atherosclerosis.
@en
prefLabel
Anti-inflammatory therapies for atherosclerosis.
@en
P356
P1476
Anti-inflammatory therapies for atherosclerosis.
@en
P2093
Göran K Hansson
P304
P356
10.1038/NRCARDIO.2015.5
P407
P50
P577
2015-02-10T00:00:00Z